A study demonstrated that the delivery of liposome-protamine-IL-22BP mRNA complex can induce tumor apoptosis, inhibit angiogenesis, and increase infiltration of immune cells, showing a promising potential for colon cancer therapy (248). Here, IL22RA2 is linked to colonic neoplasm.